Oral bioaccessibility of PTEs in soils: A review of data, influencing factors and application in human health risk assessment

Abstract

Understanding the behavior of metal(loi)ds transported from soil to humans is critical for human health risk assessment (HHRA). In the last two decades, extensive studies have been conducted to better assess human exposure to potentially toxic elements (PTEs) by estimating their oral bioaccessibility (BAc) and quantifying the influence of different factors. This study reviews the common in vitro methods used to determine the BAc of PTEs (in particular As, Cd, Cr, Ni, Pb, and Sb) under specific conditions (particularly in terms of the particle size fraction and validation status against an in vivo model). The results were compiled from soils derived from various sources and allowed the identification of the most important influencing factors of BAc (using single and multiple regression analyses), including physicochemical soil properties and the speciation of the PTEs in question. This review presents current knowledge on integrating relative bioavailability (RBA) in calculating doses from soil ingestion in the HHRA process. Depending on the jurisdiction, validated or non-validated bioaccessibility methods were used, and risks assessors applied different approaches: (i) using default assumptions (i.e., RBA of 1); (ii) considering that bioaccessibility value (BAc) accurately represents RBA (i.e., RBA equal to BAc); (iii) using regression models to convert BAc of As and Pb into RBA as proposed by the USA with the US EPA Method 1340; or (iv) applying an adjustment factor as proposed by the Netherlands and France to use BAc from UBM (Unified Barge Method) protocol. The findings from this review should help inform risk stakeholders about the uncertainties surrounding using bioaccessibility data and provide recommendations for better interpreting the results and using bioaccessibility in risk studies.